miRNA-93-5p in exosomes derived from M2 macrophages improves lipopolysaccharide-induced podocyte apoptosis by targeting Toll-like receptor 4

References

• Zimmet P, Alberti KG, Magliano DJ, et al. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12(10):616–622.
   PubMed Web of Science ®Google Scholar
• Harding JL, Pavkov ME, Magliano DJ, et al. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.
   PubMed Web of Science ®Google Scholar
• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.
   PubMed Web of Science ®Google Scholar
• Rcw M. Epidemiology of diabetes and diabetic complications in China [published correction appears in Diabetologia. 2018 Apr 18;:]. Diabetologia. 2018;61(6):1249–1260.
   PubMed Web of Science ®Google Scholar
• Fineberg D, Jandeleit-Dahm KA, Cooper ME. Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol. 2013;9(12):713–723.
   PubMed Web of Science ®Google Scholar
• Jin J, Shi Y, Gong J, et al. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res Ther. 2019;10(1):95.
   PubMed Web of Science ®Google Scholar
• Tang J, Yao D, Yan H, et al. The role of MicroRNAs in the pathogenesis of diabetic nephropathy. Int J Endocrinol. 2019;2019:8719060.
   PubMed Web of Science ®Google Scholar
• Zhou D, Zhou M, Wang Z, et al. PGRN acts as a novel regulator of mitochondrial homeostasis by facilitating mitophagy and mitochondrial biogenesis to prevent podocyte injury in diabetic nephropathy. Cell Death Dis. 2019;10(7):524.
   PubMed Web of Science ®Google Scholar
• Lei X, Zhang L, Li Z, et al. Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats. Drug Des Devel Ther. 2018;12:2785–2793.
   PubMed Web of Science ®Google Scholar
• Dai ZW, Cai KD, Xu LC, et al. Perilipin2 inhibits diabetic nephropathy-induced podocyte apoptosis by activating the PPARγ signaling pathway. Mol Cell Probes. 2020;53:101584.
   PubMed Web of Science ®Google Scholar
• Mathieson PW. The podocyte as a target for therapies–new and old. Nat Rev Nephrol. 2011;8(1):52–56.
   PubMed Web of Science ®Google Scholar
• Denhez B, Rousseau M, Dancosst DA, et al. Diabetes-induced DUSP4 reduction promotes podocyte dysfunction and progression of diabetic nephropathy. Diabetes. 2019;68(5):1026–1039.
   PubMed Web of Science ®Google Scholar
• Nagata M. Podocyte injury and its consequences. Kidney Int. 2016;89(6):1221–1230.
   PubMed Web of Science ®Google Scholar
• Fufaa GD, Weil EJ, Lemley KV, et al. Structural predictors of loss of renal function in American Indians with type 2 diabetes. Clin J Am Soc Nephrol. 2016;11(2):254–261.
   PubMed Web of Science ®Google Scholar
• Huen SC, Cantley LG. Macrophages in renal injury and repair. Annu Rev Physiol. 2017;79:449–469.
   PubMed Web of Science ®Google Scholar
• Yang H, Xie T, Li D, et al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway. Mol Metab. 2019;23:24–36.
   PubMed Web of Science ®Google Scholar
• Minton K. Macrophages: a transcription factor to call their own. Nat Rev Immunol. 2011;11(2):74.
   PubMed Web of Science ®Google Scholar
• Liu S, Shen H, Li J, et al. Loganin inhibits macrophage M1 polarization and modulates sirt1/NF-κB signaling pathway to attenuate ulcerative colitis. Bioengineered. 2020;11(1):628–639.
   PubMed Web of Science ®Google Scholar
• Müller J, Von Bernstorff W, Heidecke CD, et al. Differential S1P receptor profiles on M1- and M2-polarized macrophages affect macrophage cytokine production and migration. Biomed Res Int. 2017;2017:7584621.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Li L, Zhu L, et al. Mesenchymal stem cells elicit macrophages into M2 phenotype via improving transcription factor EB-mediated autophagy to alleviate diabetic nephropathy. Stem Cells. 2020;38(5):639–652.
   PubMed Web of Science ®Google Scholar
• Sun H, Tian J, Xian W, et al. Pentraxin-3 attenuates renal damage in diabetic nephropathy by promoting M2 macrophage differentiation. Inflammation. 2015;38(5):1739–1747.
   PubMed Web of Science ®Google Scholar
• Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–1232.
   PubMed Web of Science ®Google Scholar
• Mashouri L, Yousefi H, Aref AR, et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18(1):75.
   PubMed Web of Science ®Google Scholar
• Huang H, Liu H, Tang J, et al. M2 macrophage-derived exosomal miR-25-3p improves high glucose-induced podocytes injury through activation autophagy via inhibiting DUSP1 expression. IUBMB Life. 2020;72(12):2651–2662.
   PubMed Web of Science ®Google Scholar
• Juan CX, Mao Y, Cao Q, et al. Exosome-mediated pyroptosis of miR-93-TXNIP-NLRP3 leads to functional difference between M1 and M2 macrophages in sepsis-induced acute kidney injury. J Cell Mol Med. 2021;25(10):4786–4799.
   PubMed Web of Science ®Google Scholar
• Wu X, Showiheen SAA, Sun AR, et al. Exosomes Extraction and Identification. Methods Mol Biol. 2019;2054:81–91.
   PubMedGoogle Scholar
• Yang JX, Xie P, Li YS, et al. Osteoclast-derived miR-23a-5p-containing exosomes inhibit osteogenic differentiation by regulating Runx2. Cell Signal. 2020;70:109504.
   PubMed Web of Science ®Google Scholar
• Hua R, Pei Y, Gu H, et al. Antitumor effects of flavokawain-B flavonoid in gemcitabine-resistant lung cancer cells are mediated via mitochondrial-mediated apoptosis, ROS production, cell migration and cell invasion inhibition and blocking of PI3K/AKT Signaling pathway. J BUON. 2020;25(1):262–267.
   PubMed Web of Science ®Google Scholar
• Taylor SC, Posch A. The design of a quantitative Western blot experiment. Biomed Res Int. 2014;2014:361590.
   PubMed Web of Science ®Google Scholar
• Pritchard A, Tousif S, Wang Y, et al. Lung tumor cell-derived exosomes promote M2 Macrophage Polarization. Cells. 2020;9(5):1303.
   PubMed Web of Science ®Google Scholar
• Jozefczuk J, Adjaye J. Quantitative real-time PCR-based analysis of gene expression. Methods Enzymol. 2011;500:99–109.
   PubMed Web of Science ®Google Scholar
• Yang SS, Ma S, Dou H, et al. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment. Exp Cell Res. 2020;391(2):111983.
   PubMed Web of Science ®Google Scholar
• Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis. 2018;71(6):884–895.
   PubMed Web of Science ®Google Scholar
• Piccoli GB, Grassi G, Cabiddu G, et al. Diabetic kidney disease: a syndrome rather than a single disease. Rev Diabet Stud. 2015;12(1–2):87–109.
   PubMedGoogle Scholar
• Chen Y, Liu Q, Shan Z, et al. Catalpol ameliorates podocyte injury by stabilizing cytoskeleton and enhancing autophagy in diabetic nephropathy. Front Pharmacol. 2019;10:1477.
   PubMed Web of Science ®Google Scholar
• Inoue R, Asanuma K, Seki T, et al. New therapeutic insights for chronic kidney disease provided by podocytology. Nihon Yakurigaku Zasshi. 2014;143(1):27–33.
   PubMedGoogle Scholar
• Zhou L, Liu Y. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease. Nat Rev Nephrol. 2015;11(9):535–545.
   PubMed Web of Science ®Google Scholar
• Liu M, Liang K, Zhen J, et al. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nat Commun. 2017;8(1):413.
   PubMed Web of Science ®Google Scholar
• Torban E, Braun F, Wanner N, et al. From podocyte biology to novel cures for glomerular disease. Kidney Int. 2019;96(4):850–861.
   PubMed Web of Science ®Google Scholar
• Kravets I, Mallipattu SK. The role of podocytes and podocyte-associated biomarkers in diagnosis and treatment of diabetic kidney disease. J Endocr Soc. 2020;4(4):bvaa029.
   PubMed Web of Science ®Google Scholar
• Mallipattu SK, He JC. The podocyte as a direct target for treatment of glomerular disease? Am J Physiol Renal Physiol. 2016;311(1):F46–F51.
   PubMed Web of Science ®Google Scholar
• Ji L, Chen Y, Wang H, et al. Overexpression of Sirt6 promotes M2 macrophage transformation, alleviating renal injury in diabetic nephropathy. Int J Oncol. 2019;55(1):103–115.
   PubMed Web of Science ®Google Scholar
• Guo Y, Song Z, Zhou M, et al. Infiltrating macrophages in diabetic nephropathy promote podocytes apoptosis via TNF-α-ROS-p38MAPK pathway. Oncotarget. 2017;8(32):53276–53287.
   PubMedGoogle Scholar
• Han J, Pang X, Zhang Y, et al. Hirudin protects against kidney damage in streptozotocin-induced diabetic nephropathy rats by inhibiting inflammation via P38 MAPK/NF-κB pathway. Drug Des Devel Ther. 2020;14:3223–3234.
   PubMed Web of Science ®Google Scholar
• Abe H, Sakurai A, Ono H, et al. Urinary exosomal mRNA of WT1 as diagnostic and prognostic biomarker for diabetic nephropathy. J Med Invest. 2018;65(3.4):208–215.
   PubMed Web of Science ®Google Scholar
• Sakurai A, Ono H, Ochi A, et al. Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy. PLoS One. 2019;14(5):e0216788.
   PubMed Web of Science ®Google Scholar
• Su H, Qiao J, Hu J, et al. Podocyte-derived extracellular vesicles mediate renal proximal tubule cells dedifferentiation via microRNA-221 in diabetic nephropathy. Mol Cell Endocrinol. 2020;518:111034.
   PubMed Web of Science ®Google Scholar
• Jin J, Wang Y, Zhao L, et al. Exosomal miRNA-215-5p derived from adipose-derived stem cells attenuates epithelial-mesenchymal transition of podocytes by Inhibiting ZEB2. Biomed Res Int. 2020;2020:2685305.
   PubMed Web of Science ®Google Scholar
• Duan YR, Chen BP, Chen F, et al. Exosomal microRNA-16-5p from human urine-derived stem cells ameliorates diabetic nephropathy through protection of podocyte [published online ahead of print, 2019 Sep 30]. J Cell Mol Med. 2019;25(23):10798–10813.
   PubMedGoogle Scholar
• Wu Y, Wu M, Yang J, et al. Silencing CircHIPK3 sponges miR-93-5p to inhibit the activation of Rac1/PI3K/AKT pathway and improves myocardial infarction-induced cardiac dysfunction. Front Cardiovasc Med. 2021;8:645378.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang X, Wang P, et al. Knockdown of circ-FANCA alleviates LPS-induced HK2 cell injury via targeting miR-93-5p/OXSR1 axis in septic acute kidney injury. Diabetol Metab Syndr. 2021;13(1):7.
   PubMed Web of Science ®Google Scholar
• Yang J, Wu L, Liu S, et al. Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p/TXNIP axis. Med Microbiol Immunol. 2021;210(2–3):121–132.
   PubMed Web of Science ®Google Scholar
• He Z, Wang H, Yue L. Endothelial progenitor cells-secreted extracellular vesicles containing microRNA-93-5p confer protection against sepsis-induced acute kidney injury via the KDM6B/H3K27me3/TNF-α axis. Exp Cell Res. 2020;395(2):112173.
   PubMed Web of Science ®Google Scholar
• Ma J, Chadban SJ, Zhao CY, et al. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. PLoS One. 2014;9(5):e97985.
   PubMed Web of Science ®Google Scholar
• Ren H, Hu X, Liu Y, et al. Salvia przewalskii extract of total phenolic acids inhibit TLR4 signaling activation in podocyte injury induced by puromycin aminonucleoside in vitro. Ren Fail. 2018;40(1):273–279.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu Z, Ma F, et al. Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway. Biomed Pharmacother. 2018;107:1393–1401.
   PubMed Web of Science ®Google Scholar